glycopyrrolate has been researched along with haloperidol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jäppinen, A; Kokki, H; Naaranlahti, TJ; Rasi, AS | 1 |
| Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S | 1 |
| Bükki, J; Dickman, A; Fürst, CJ; Hagelin, CL; Lindqvist, O; Lunder, U; Lundquist, G; Rasmussen, BH; Sauter, S; Tishelman, C | 1 |
3 other study(ies) available for glycopyrrolate and haloperidol
| Article | Year |
|---|---|
Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution.
Topics: Analgesics, Opioid; Antipsychotic Agents; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Drug Combinations; Drug Contamination; Drug Packaging; Drug Stability; Glycopyrrolate; Haloperidol; Muscarinic Antagonists; Pharmaceutical Solutions; Reference Standards; Sodium Chloride; Syringes; Temperature; Time Factors | 1999 |
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cortical; Electroconvulsive Therapy; Female; Glycopyrrolate; Haloperidol; Humans; Muscarinic Antagonists; Olanzapine; Panic; Schizophrenia, Paranoid; Treatment Outcome; Trihexyphenidyl | 2012 |
Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion.
Topics: Adult; Aged; Analgesics, Opioid; Anti-Anxiety Agents; Antipsychotic Agents; Delphi Technique; Drugs, Essential; European Union; Female; Glycopyrrolate; Haloperidol; Humans; Male; Midazolam; Middle Aged; Morphine; Muscarinic Antagonists; Palliative Care; Psychomotor Agitation; Scopolamine | 2013 |